Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Human T-cell leukaemia virus

G Franchini1, H Streicher

  • 1Animal Model and Vaccine Section, National Cancer Institute, Bethesda, MD 20892, USA.

Bailliere'S Clinical Haematology
|March 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

How is mental health associated with dental health in refugee children?

European archives of paediatric dentistry : official journal of the European Academy of Paediatric Dentistry·2026
Same author

Fatty Acid and Retinol-Binding Protein: Unusual Protein Conformational and Cavity Changes Dictated by Ligand Fluctuations.

Journal of chemical information and modeling·2019
Same author

[Inpatient multimodal pain therapy : Additive value of neuromuscular core stability exercises for chronic back pain].

Schmerz (Berlin, Germany)·2016
Same author

[Causes and calculated predictors of a Duchenne gait in adolescents and young adults with cerebral palsy].

Zeitschrift fur Orthopadie und Unfallchirurgie·2015
Same author

MHC class II nomenclature in the rat.

Immunology today·2014
Same author

Consensus guidelines for the conduct and reporting of clinical trials in systemic light-chain amyloidosis.

Leukemia·2012
Same journal

Current status of stem cell therapy and prospects for gene therapy for the disorders of globin synthesis.

Bailliere's clinical haematology·2000
Same journal

Pharmacological therapy.

Bailliere's clinical haematology·2000
Same journal

Prenatal diagnosis and screening of the haemoglobinopathies.

Bailliere's clinical haematology·2000
Same journal

Sickle cell disease: clinical management.

Bailliere's clinical haematology·2000
Same journal

Pathophysiology of sickle cell disease.

Bailliere's clinical haematology·2000
Same journal

Thalassaemia: clinical management.

Bailliere's clinical haematology·2000
See all related articles

Human T-lymphotropic virus type I (HTLV-I) replication offers insights into T-cell regulation. Preventing HTLV-I infection, through measures like reduced breastfeeding and future vaccines, is key to eliminating associated diseases.

Area of Science:

  • Virology
  • Immunology
  • Molecular Biology

Background:

  • Human T-lymphotropic virus type I (HTLV-I) exhibits complex replication, serving as a model for T-cell regulation.
  • The pleiotropic effects of HTLV-I present a significant challenge in understanding host-pathogen interactions.
  • Immunological factors are implicated in HTLV-I-associated neurological conditions, uveitis, and arthritis.

Purpose of the Study:

  • To explore the regulatory mechanisms of HTLV-I replication in T-cells.
  • To investigate the host factors and viral proteins (e.g., tax, p12') involved in HTLV-I pathogenesis.
  • To assess strategies for preventing HTLV-I infection and its associated diseases.

Main Methods:

  • Analysis of HTLV-I replication pathways in T-cells.

Related Experiment Videos

  • Investigation of viral protein functions in T-cell proliferation.
  • Epidemiological studies on HTLV and simian T-lymphotropic virus (STLV) transmission and phylogeny.

    • Main Results:

    • HTLV-I replication involves complex cellular and viral regulatory pathways.
    • Viral proteins like tax and p12' may contribute to T-cell proliferation, but the leukaemic phase remains unclear.
    • Reduced breastfeeding by seropositive mothers in Japan shows promising results in disease prevention.

    Conclusions:

    • Prevention of HTLV-I infection is crucial due to the lack of effective therapies for HTLV-I-induced leukemia.
    • Vaccination is likely essential for preventing HTLV-I spread in developing countries.
    • Molecular epidemiology aids in understanding HTLV/STLV phylogeny, human migration, and the role of nonhuman primates as reservoirs.